To complement its own research activities, Cytos Biotechnology has established a scientific network with several academic research institutions around the world. These contacts not only allow fruitful discussions with experts in the various fields, but give Cytos Biotechnology also prime access to cutting-edge technologies, disease-specific know-how, and additional specimens and research materials. In addition, several projects are supported by grants from the Swiss Commission for Technology and Innovation ("Kommission für Technologie und Innovation" KTI) and from the European Union (European Commission’s Seventh Framework Program).    

Among the collaboration partners of Cytos Biotechnology are:  

•  A*STAR's Singapore Immunology Network (SIgN), Singapore
• Emory Vaccine Institute, Atlanta, USA
• ETH Zurich, Switzerland
• Institute of Biotechnology, Vilnius, Lithuania
• Justus Liebig Universität Giessen, Germany
• Ludwig Institute, Lausanne, Switzerland
• University of Basel, Switzerland
• University of Konstanz, Germany
• University of Latvia, Riga, Latvia
• University of Lausanne, Switzerland
• University of Milano, Italy
• University of Munich, Germany
• University Pierre et Marie Curie, Paris, France
• University of Zurich, Switzerland